Gülçin Çelebi

2PUBLICATIONS
6CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 21, 2025
Dynamic blood-based biomarkers predict early response to ipilimumab and nivolumab in advanced melanoma.

Gökhan Şahin, Caner Acar, Haydar Çağatay Yüksel

|Dec 20, 2024
Efficacy and prognostic factors of anti-PD1 and nivolumab-ipilimumab therapy in advanced melanoma patients resistant to prior ICI treatment.

Caner Acar, Haydar Çağatay Yüksel, Gökhan Şahin

Pageof 1

Frequent Collaborators

2 joint publications

Caner Acar

2 joint publications

Haydar Çağatay Yüksel

2 joint publications

Gökhan Şahin

2 joint publications

Fatma Pınar Açar